IP Library Granted Patent US 8,536,373
Granted Patent B2
US 8,536,373 · App. 12/442,162 · Granted Sep 17, 2013

Method of production of 9-cis-retinoic acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,536,373
App. No.
12/442,162
Granted
Sep 17, 2013
Kind
B2
Abstract

Improved method of production of 9-(Z)-retinoic acid, in which a) a β-formyl-crotonic acid C 1 -C 10 alkyl or phenyl ester is reacted with an isolated 9-(Z)—C 15 -triarylphosphonium salt by the Wittig reaction in the presence of a base to the corresponding 9-(Z)-retinoic acid ester; which b) is then saponified with a base to the corresponding 9-(Z)-retinoic acid carboxylate and then, following protonation with an acid, the desired 9-(Z)-retinoic acid is obtained, and improved method for the enrichment and isolation of the 9-(Z)—C 15 -triarylphosphonium salt.

Claims (11)

1. A method for producing 9-(Z)-retinoic acid, comprising:

a) reacting a β-formyl-crotonic acid —C 1 -C 10 alkyl or phenyl ester with an isolated 9-(Z)—C 15 -triarylphosphonium salt by a Wittig reaction in the presence of a base to form a reaction mixture comprising a corresponding 9-(Z)-retinoic acid ester,

b) saponifying the 9-(Z)-retinoic acid ester with a base to form the corresponding 9-(Z)-retinoic acid carboxylate, and then

c) protonating the 9-(Z)-retinoic acid carboxylate with an acid to obtain 9-(Z)-retinoic acid.

2. The method according to claim 1 , wherein the isolated 9-(Z)—C 15 -triarylphosphonium salt is a compound of formula (I)

in which Aryl represents an optionally substituted C 6 -C 10 aryl residue and X represents a halogen.

3. The method according to claim 1 , wherein the reaction in step a) takes place in a solvent mixture of a C 1 -C 4 alcohol and a non-polar solvent selected from the group consisting of methylene chloride, hexane and toluene.

4. The method according to claim 1 , wherein the reaction in step a) is carried out at a reaction temperature from −40° C. to +40° C.

5. The method according to claim 1 , wherein the reaction in step a) takes place in the presence of a base selected from the group consisting of the alkali-metal or alkaline-earth C 1 -C 4 alcoholates, carbonates, hydroxides, hydrides and amides.

6. The method according to claim 1 , wherein the 9-(Z)-retinoic acid ester obtained according to step a) is not isolated from the reaction mixture, and wherein step a) comprises after the end of the Wittig reaction the steps of optionally heating the reaction mixture is to room temperature, and wherein step b) includes saponifying the 9-(Z)-retinoic acid ester with an aqueous alkali-metal or alkaline-earth hydroxide solution as base.

7. The method according to claim 1 , wherein step b) sequentially comprises (b1) adding the base to form an alkaline reaction mixture, b2) distilling off the low-boiling substances, b3) cooling the alkaline reaction mixture and then, b3) adding an acid to the cooled alkaline reaction mixture to thereby release and crystallize the desired 9-(Z)-retinoic acid.

Assignments (5)
CHANGE OF NAME Recorded Sep 23, 2025
From: DPX HOLDINGS B.V.
To: PATHEON HOLDINGS I B.V.
Reel/Frame 072951/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2014
From: DSM IP ASSETS B.V.
To: JLL/DELTA DUTCH NEWCO B.V.
Reel/Frame 034282/0574 →
CHANGE OF NAME Recorded Dec 1, 2014
From: JLL/DELTA DUTCH NEWCO B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 034500/0795 →
CHANGE OF ADDRESS Recorded Dec 1, 2014
From: DPX HOLDINGS B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 034500/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2009
From: STANEK, M.; ESSL, S.; KNOPP, M.; KUEBEL, E.
To: DSM IP ASSETS B.V.
Reel/Frame 023613/0308 →